the key takeaway and company maker (Mark #1) for mine ...IHL675A = anti-inflammatory disease related 'multi - use medication'
absolutely huge
Congratulations to IHL management and medical research team - to be aligned with and invested in such an innovative, forward thinking, progressive team who continually execute on strategy and development is fortunate for every invested share holder and doubly so for sufferers in the areas being addressed by IHL.
